Analyses of Gnai3-iresGFP reporter mice reveal unknown Gα

Veronika Leiss, Ellen Reisinger, Annika Speidel, Sandra Beer-Hammer, Bernd Nürnberg

Open access · goldAbstract read

In one paragraph

Article in Scientific reports, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it

0cells of the map it votes in

1citing papers in PubMed

0.2field-weighted citation impact, top 51% of its field

1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 2 citations in OpenAlex.

Characterization of Dual-Acting AACS pharmacology & translational science · 2022
Article

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Veronika LeissDepartment of Pharmacology, Experimental Therapy and Toxicology, Institute of Experimental and Clinical Pharmacology and Pharmacogenomics, and ICePhA Mouse Clinic, University of Tübingen, Wilhelmstraße 56, 72074, Tübingen, Germany.

Ellen ReisingerDepartment of Otolaryngology-Head and Neck Surgery, Gene Therapy for Hearing Impairment Group, University of Tübingen, Medical Center, Elfriede-Aulhorn-Straße 5, 72076, Tübingen, Germany.

Annika SpeidelDepartment of Pharmacology, Experimental Therapy and Toxicology, Institute of Experimental and Clinical Pharmacology and Pharmacogenomics, and ICePhA Mouse Clinic, University of Tübingen, Wilhelmstraße 56, 72074, Tübingen, Germany.

Sandra Beer-HammerDepartment of Pharmacology, Experimental Therapy and Toxicology, Institute of Experimental and Clinical Pharmacology and Pharmacogenomics, and ICePhA Mouse Clinic, University of Tübingen, Wilhelmstraße 56, 72074, Tübingen, Germany. sandra.beer-hammer@uni-tuebingen.de.

Bernd NürnbergDepartment of Pharmacology, Experimental Therapy and Toxicology, Institute of Experimental and Clinical Pharmacology and Pharmacogenomics, and ICePhA Mouse Clinic, University of Tübingen, Wilhelmstraße 56, 72074, Tübingen, Germany.

University of Tübingen · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Inhibitory G proteins (G

Indexed as

Genes, ReporterAnimalsFlow CytometryGene Expression ProfilingGenotypeGreen Fluorescent ProteinsGTP-Binding Protein alpha Subunits, Gi-GoHeterozygoteMiceMice, Inbred C57BLSpleenThymus GlandGNAI3 protein, humanGreen Fluorescent ProteinsGTP-Binding Protein alpha Subunits, Gi-Go

Identifiers

PMID34253772

DOI10.1038/s41598-021-93591-0

PMCPMC8275620

OpenAlexW3178676456

What OpenQuestion holds

Textmetadata

LicenceCC BY

Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.